1 min read
Wedbush Calls GlobalFoundries’ Atlas Trial a Positive Step
The firm expects the humanoid robot trial to have little near-term financial impact on the semiconductor foundry.

Wedbush Securities views GlobalFoundries’ trial of Boston Dynamics’ Atlas humanoid robot as a positive step, while expecting little near-term financial impact on the semiconductor foundry.